<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 6-year-old male with prior metastatic <z:hpo ids='HP_0009919'>retinoblastoma</z:hpo> developed a therapy linked <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Whole bone marrow cytogenetics showed <z:mp ids='MP_0004026'>monosomy</z:mp> 7 and a marker chromosome </plain></SENT>
<SENT sid="2" pm="."><plain>To determine the progenitor level of origin of the malignant clone, we studied the karyotypes of marrow erythroid and granulocyte/macrophage colonies grown in <z:chebi fb="1" ids="53448">methyl cellulose</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> erythroid and granulocyte/macrophage colonies had an abnormal karyotype with 45 chromosomes (<z:mp ids='MP_0004026'>monosomy</z:mp> 7) and several colonies contained the marker chromosome </plain></SENT>
<SENT sid="4" pm="."><plain>These findings give direct evidence that this patient's <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> involved an early stem cell which was capable of both erythroid and granulocyte differentiation </plain></SENT>
</text></document>